IRBM, AACR IRBM divulgará forte eficácia antitumoral de novos agentes pré-clínicos contra tumores cerebrais agressivos e leucemia linfoblástica aguda na AACR
07.08.2025 - 18:03:08
IRBM S.p.A. United Kingdom United States of America France Germany Spain Italy California